CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 80 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +2,331 | $68.96 | $161K | 1,567,464 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +39,066 | $68.96 | $2.7M | 18,476,927 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +1,056 | $71.48 | $75K | 1,568,520 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +17,698 | $71.48 | $1.3M | 18,494,625 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +16,641 | $72.39 | $1.2M | 1,585,161 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +278,978 | $72.39 | $20.2M | 18,773,603 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +4,696 | $73.08 | $343K | 1,589,857 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +78,726 | $73.08 | $5.8M | 18,852,329 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +4,577 | $73.97 | $339K | 1,594,434 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +76,723 | $73.97 | $5.7M | 18,929,052 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +1,924 | $75.52 | $145K | 1,596,358 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +32,261 | $75.52 | $2.4M | 18,961,313 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +3,681 | $76.35 | $281K | 1,600,039 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +61,700 | $76.35 | $4.7M | 19,023,013 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +2,884 | $77.43 | $223K | 1,602,923 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +48,350 | $77.43 | $3.7M | 19,071,363 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +2,969 | $78.57 | $233K | 1,605,892 |
| 2026-09-28 | BAKER BROS. ADVISORS LP Director | Purchase | +49,771 | $78.57 | $3.9M | 19,121,134 |
| 2026-09-25 | PERLROTH VICTOR Chairman and CEO | Option exercise | +600,000 | $5.38 | $3.2M | 2,995,538 |
| 2026-09-25 | PERLROTH VICTOR Chairman and CEO | Option exercise | +365,840 | $2.49 | $911K | 3,361,378 |
Page 5 of 20 · 388 trades